GE HealthCare

Company Overview

GE HealthCare specializes in medical technology, pharmaceutical diagnostics, and digital solutions. In 2023, General Electric Co. completed its spin-off of GE HealthCare. It operates in four segments: imaging, ultrasound, patient care solutions (PCS), and pharmaceutical diagnostics (PDx).

The patient care solutions portfolio includes monitoring, life support, diagnostic cardiology, consumables, and digital solutions that enhance patient monitoring, clinical decision-making, and maternal-infant care. In diagnostic cardiology, GE Healthcare offers resting and stress ECG systems, along with digital platforms featuring advanced interpretation algorithms. Its connected ecosystem supports cardiac monitoring by capturing, analyzing, and managing ECG data across hospital and home settings to improve cardiovascular diagnosis and maintain care continuity. GE HealthCare has a broad geographical reach with a market presence in over 160 countries.

Financial Highlights (FY 2025)

Company's Business Segments

• Imaging : Molecular Imaging, Computed Tomography, Magnetic Resonance, Image-Guided Therapies, Women’s Health, and X-ray
• Advanced Visualization Solutions (AVS) : CardioVascular and Interventional Solutions, Comprehensive Care Ultrasound, Women’s Health Ultrasound, Surgical Innovations products.
• Patient Care Solutions (PCS) : Patient Monitoring, Anesthesia Delivery and Respiratory Care, Diagnostic Cardiology, Maternal Infant Care, and Consumables and Services connected by and differentiated with their digital solutions
• Pharmaceutical Diagnostics (SPDx) : Contrast Media and Molecular Imaging